CSIMarket
 


Immucell Corp  (ICCC)
Other Ticker:  
 

Immucell's Quick Ratio

ICCC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




ICCC Quick Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Current Liabilities Change -14.47 % 12.7 % -11.39 % 5.35 % 17.68 %
Y / Y Cash & cash equivalent Change 30.58 % -2.75 % -9.43 % -40.72 % -22.57 %
Quick Ratio MRQ 5.27 3.24 3.59 3.28 3.45
Overall Ranking # # # # #
Seq. Current Liabilities Change -3.15 % -5.1 % 22.72 % -24.17 % 27.61 %
Seq. Cash & cash equivalent Change 57.21 % -14.34 % 34.44 % -27.87 % 17.09 %



Quick Ratio second quarter 2021 Comment
Immucell's Cash & cash equivalent grew by 57.21 % in II. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Immucell's Quick Ratio to 5.27, Quick Ratio remained below Immucell Corp average.

Within In Vitro & In Vivo Diagnostic Substances industry 52 other companies have achieved higher Quick Ratio than Immucell in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are ICCC Segments?
See Quick Ratio ICCC on the trailing twelve month basis
Quick Ratio second quarter 2021 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 53
Healthcare Sector # 395
Overall Market # 772


Quick Ratio Statistics
High Average Low
11.81 5.44 0.64
(Mar 31 2016)   (Sep 30 2017)




Financial Statements
Immucell's Current Liabilities $ 2 Millions Visit ICCC's Balance sheet
Immucell's Cash & cash equivalent $ 11 Millions Visit ICCC's Balance sheet
Source of ICCC's Sales Visit ICCC's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2021, within In Vitro & In Vivo Diagnostic Substances Industry Quick RatioJun 30 2021 MRQ Cash & cash equivalentJun 30 2021 MRQ Current Liabilities
Celldex Therapeutics inc   11.32 $ 164.037  Millions$ 14.488  Millions
Achieve Life Sciences Inc   8.99 $ 42.001  Millions$ 4.670  Millions
Intellia Therapeutics Inc   7.15 $ 529.019  Millions$ 73.963  Millions
Neogen Corp  7.11 $ 381.087  Millions$ 53.599  Millions
Heska Corporation  5.91 $ 245.153  Millions$ 41.481  Millions
Lucira Health Inc   5.65 $ 161.662  Millions$ 28.635  Millions
Immucell Corp  5.27 $ 10.701  Millions$ 2.032  Millions
Volitionrx Limited  5.17 $ 27.913  Millions$ 5.398  Millions
Quotient Limited  2.87 $ 166.659  Millions$ 58.051  Millions
Quidel Corporation  2.83 $ 593.224  Millions$ 209.267  Millions
Oncocyte Corporation  2.35 $ 46.469  Millions$ 19.775  Millions
Meridian Bioscience Inc   1.91 $ 70.012  Millions$ 36.702  Millions
Navidea Biopharmaceuticals Inc   1.77 $ 7.114  Millions$ 4.025  Millions
Lantheus Holdings Inc   1.24 $ 91.500  Millions$ 73.826  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SUND's Profile

Stock Price

SUND's Financials

Business Description

Fundamentals

Charts & Quotes

SUND's News

Suppliers

SUND's Competitors

Customers & Markets

Economic Indicators

SUND's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071